Astrazeneca Pharma India informs about loss of share certificate

02 Jan 2020 Evaluate

Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, Astrazeneca Pharma India has informed that the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate as per attached details.

The above information is a part of company’s filings submitted to BSE.


Astrazeneca Pharma I Share Price

8354.45 -141.25 (-1.66%)
19-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1744.35
Dr. Reddys Lab 1274.05
Cipla 1238.65
Zydus Lifesciences 876.35
Lupin 2253.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×